Skip to main content
S&P 5007,376.86+0.31%DOW51,285.73-0.46%NASDAQ24,579.42+1.09%BTC$75,946.00-0.25%ETH$2,243.57+0.21%GOLD$4,079.50-0.83%OIL$90.34-0.20%
Smart Investors Daily
SID Premium
BR

NASDAQ · BRKRP

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A

Healthcare · Medical - Devices

$446.63

Up+$19.95 (+4.68%)

Updated Nov 8, 2026, 11:00 AM

SID Score

7.5/10

Composite research score

Smart Money

58/100

Neutral

Market cap
54.39B
P/E ratio
-355.31
Dividend yield
0.43%
52-week range
$264.30 – $498.45
Volume
994
Avg. volume
27.82K

Price performance · BRKRP

BRKRP price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 6, 2026

BRKRP closed at $446.63 after 20 trading sessions, up 7.57% for the selected period.

Last close
$446.63
Period change
+7.57%
Period low
$405.85
Period high
$464.69
Daily close
View OHLC price history
BRKRP OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 6, 2026$444.72$446.63$437.16$446.63994
Nov 5, 2026$432.83$447.85$426.13$426.6815.26K
Nov 4, 2026$483.48$498.45$444.66$464.6931.73K
Nov 3, 2026$421.80$435.085$415.07$415.0713.46K
Nov 2, 2026$409.72$417.01$409.65$411.532.71K
Oct 30, 2026$435.30$435.50$413.22$422.3914.02K
Oct 29, 2026$448.35$456.49$448.35$454.2016.16K
Oct 28, 2026$450.41$462.11$450.41$455.433.15K
Oct 27, 2026$432.93$446.32$432.93$446.322.37K
Oct 26, 2026$427.065$427.96$425.71$425.711.85K
Oct 23, 2026$420.6396$421.445$419.43$421.445670
Oct 22, 2026$445.23$445.26$410.79$420.492.12K
Oct 21, 2026$423.52$435.91$423.52$430.2652.59K
Oct 20, 2026$409.81$419.09$409.81$419.09927
Oct 19, 2026$413.82$413.82$407.97$410.612.58K
Oct 16, 2026$412.79$412.79$402.415$405.853.07K
Oct 15, 2026$406.46$420.18$406.46$417.621.26K
Oct 14, 2026$412.25$427.92$406.71$417.4752.25K
Oct 13, 2026$412.80$417.37$407.65$417.372.19K
Oct 12, 2026$420.03$420.03$414.48$415.201.01K

Latest BRKRP news

The latest Smart Investors Daily articles mentioning BRKRP.

Stock researchCompany · Overview

BRKRP research

Overview

Company profile and research snapshot.

Company profile

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
12
BRKRP recent ratings
DateFirmRatingTarget
Nov 5, 2026Leerink PartnersOutperform—
Nov 5, 2026CitigroupNeutral—
Oct 14, 2026JP MorganNeutral—
Oct 13, 2026TD CowenHold—
Oct 7, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 5, 2026

Bruker Stock Earnings Beat Has The Bull Case Changed?

Bruker reported Q3 2026 sales of US$874 million and EPS of US$0.56, alongside a US$174.5 million non cash goodwill impairment and continued net losses for the period. Despite the impairment charges and reported loss, Bruker delivered stronger non GAAP margins, reaffirmed its 2026 outlook and highlighted solid bookings in areas like US academic funding, China and semiconductor metrology. We will now look at how Bruker’s investment narrative lines up with this quarter’s stronger margins and...

Yahoo · Nov 5, 2026

Bruker (BRKR) Jumped, What Is Behind The Fresh Attention?

Bruker (BRKR) reported Q3 2026 results and updated guidance, combining margin gains and solid bookings with a reaffirmed outlook and a more positive initial view on 2027. Bruker’s latest update landed alongside a sharp 1-day share price return of 12.9% to US$63.79. This follows a 90-day share price return of 24.4% and a 1-year total shareholder return of 59.35%, suggesting momentum has been rebuilding as investors react to margin gains, reaffirmed 2026 guidance and a more upbeat early view on...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By